Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Publisher Name :
Date: 02-Jul-2015
No. of pages: 182
Inquire Before Buying

Over the years, the global healthcare industry has witnessed a paradigm shift, and is now increasingly focused on minimally invasive therapies that not only treats a wide range of chronic and refractory disorders but also have fewer sideeffects.The demand for neuromodulation has increased significantly, because of patients’ preference for minimally invasive surgeries.Moreover, these therapies are reversible, which allows physicians to cease treatment, as and when required by removing the stimulating devices.

Based on technology, the internal neuromodulation segment is expected to be the largest and fastest-growing component segment in 2015. In internal neuromodulation category, spinal cord stimulation segment is expected to dominate the neuromodulation market in 2015.However, the deep brain stimulation segment is expected to grow at the highest CAGR from 2015 to 2020. In the external neuromodulation category, the transcutaneous electrical nerve stimulation segment is expected to be the largest segment in the neuromodulation market. However, the transcranial magnetic stimulation segment has registered the highest CAGR during the forecast period.

North America is expected to account for the largest share of the neuromodulation market, followed by Europe, Asia-Pacific, and rest of the world (RoW)in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of equipment and devices involved in neuromodulation.

The global neuromodulation market witnesses high-competitive intensity as there are several big and small firms with similar product offerings.These companies adopt various strategies (agreements, partnerships, mergers, collaborations,acquisitions,new product launches, market development, geographical expansions, and acquisitions) to increase their market shares and establish a strong foothold in the global neuromodulation market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps companies, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies(market penetration, product development/innovation,market development, market diversification, and competitive assessment)for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration:Comprehensive information on the product portfolios offered by top players in the neuromodulation market. The report analyzes the neuromodulation market by technology and application

  • Product Development/Innovation:Detailed insights on the upcoming technologies, research and development activities, and new product launches in the neuromodulation market

  • Market Development:Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various neuromodulation technologies across regions

  • Market Diversification:Exhaustive information about new products, untapped regions, recent developments, and investments in the neuromodulation market

  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the neuromodulation market

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.2 Primary Research
2.1.3 Key Data From Primary Sources
2.1.4 Key Insights From Primary Sources
2.1.4.1 Key Industry Insights
2.1.5 Market Size Estimation Methodology
2.1.6 Research Design
2.1.7 Market Data Validation and Triangulation
2.1.8 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Market Overview of Neuromodulation
4.2 Global Neuromodulation Market, By Type
4.3 Geographic Analysis of the Deep Brain Stimulation Market, By Application
4.4 Internal Neuromodulation Market, By Modality
4.5 Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Segmentation of Neuromodulation
5.3 Market Dynamics of Neuromodulation
5.1 Drivers
5.1.1.1 Rising Prevalence of Neurological Disorders to Spur Market Growth
5.1.1.2 Unprecedented Increase in the Aging Population to Fuel Market Growth
5.1.1.3 Strong Product Pipeline to Propel the Market
5.1.1.4 Expanded Target Applications and New Indications are Expected to Stimulate the Growth of Neuromodulation Devices
5.1.1.5 Investments and Funds – an Impetus for Market Growth
5.2 Restraints
5.2.1.1 Unfavorable Reimbursement Scenario Hinders Market Growth
5.2.1.2 Lack of Trained Professionals Likely to Hamper Market Growth
5.3 Opportunities
5.3.1.1 Expansion in Emerging Economies

6 Global Neuromodulation Market, By Technology
6.1 Introduction
6.2 Internal Neuromodulation
6.2.1 Spinal Cord Stimulation (SCS)
6.2.2 Deep Brain Stimulation (DBS)
6.2.3 Vagus Nerve Stimulation (VNS)
6.2.4 Sacral Nerve Stimulation (SNS)
6.2.5 Gastric Electrical Stimulation (GES)
6.3 External Neuromodulation (Non-Invasive)
6.3.1 Transcutaneous Electrical Nerve Stimulation (Tens)
6.3.2 Transcranial Magnetic Stimulation (TMS)
6.3.3 Respiratory Electrical Stimulation (RES)

7 Global Neuromodulation Market, By Application
7.1 Introduction
7.2 Spinal Cord Stimulation (SCS) Market, By Application
7.2.1 Failed Back Syndrome (FBSS)
7.2.2 Chronic Pain
7.2.3 Ischemia
7.3 Deep Brain Stimulation (DBS) Market, By Application
7.3.1 Parkinson’s Disease
7.3.2 Tremor
7.3.3 Depression
7.3.4 Other Dbs Applications
7.4 Sacral Nerve Stimulation Market, By Application
7.4.1 Urine Incontinence
7.4.2 Fecal Incontinence
7.5 Vagus Nerve Stimulation Market, By Application
7.5.1 Epilepsy
7.5.2 Other Vns Applications
7.6 Gastric Electrical Stimulation Market, By Application
7.6.1 Gastroparesis
7.6.2 Obesity
7.7 Transcutaneous Electrical Nerve Stimulation Market, By Application
7.7.1 Treatment Resistant Depression
7.7.2 Other Tens Applications
7.8 Repetitive Transcranial Magnetic Stimulation Market, By Application
7.8.1 Depression
7.8.2 Migraine Headache
7.9 Respiratory Electrical Stimulation Market, By Application
7.9.1 Spinal Cord Injury

8 Neuromodulation Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Prevalence of Chronic Diseases In The U.S.
8.2.1.2 Increasing Aging Population In The U.S.
8.2.1.3 Increasing Lyme Disease Cases In The U.S.
8.2.1.4 Conferences & Annual Meetings To Increase Exposure of Neuromodulation
8.2.2 Canada
8.2.2.1 Increasing Incidence of Lyme Disease In Canada
8.2.2.2 Increasing Incidences of Cancer And Diabetes
8.2.3 Europe
8.2.3.1.1 Rapidly Aging Population In Europe
8.2.3.1.2 Conferences & Annual Meetings To Increase Exposure To Neuromodulation in the European Market
8.2.3.2 Germany
8.2.3.2.1 Rising Prevalence of Parkinson’s Disease In Germany
8.2.3.3 U.K.
8.2.3.3.1 Rising Prevalence of Diabetes In The U.K.
8.2.3.3.2 Rise In CVD Prevalence In The U.K.
8.2.3.4 France
8.2.3.4.1 Rising Incidences of Alzheimer's Disease And Dementia
8.2.3.5 Rest of Europe
8.2.3.5.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine
8.2.4 Asia-Pacific
8.2.4.1 Japan
8.2.4.1.1 Rising Adoption of Neurostimulation
8.2.4.2 China
8.2.4.2.1 High Diabetes Incidences And Rapidly Aging Population
8.2.4.3 India
8.2.4.3.1 Increasing Geriatric Population & High Diabetes Incidence
8.2.4.3.2 Conferences On Neuromodulation & Pain Management In India
8.2.4.4 Rest of Asia-Pacific (ROAPAC)
8.2.4.4.1 Increasing Prevalence of Parkinson’s Disease In Singapore
8.2.4.4.2 Conferences On Neuromodulation In Australia
8.2.5 Rest of The World
8.2.5.1.1 Increasing Incidences of Cancer In Latin America
8.2.5.1.2 Rise In Aging Population & Prevalence of Diabetes

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis fo Neuromodulation, By Key Player
9.2.1 Introduction
9.3 Medtronic, Inc.
9.4 Boston Scientific Corporation
9.5 ST. Jude Medical, Inc.
9.6 Competitive Scenario
9.6.1 Market Development of Neuromodulation
9.6.2 Agreements, Collaborations, Mergers, and Partnerships
9.6.3 New Product Launches
9.6.4 Acquisitions
9.6.5 Expansion

10 Company Profiles
10.1 Introduction
10.2 Medtronic, Inc.
10.2.1 Business Overview
10.2.2 Medtronic, Inc.: Company Snapshot
10.2.3 Products & Services
10.2.4 Recent Developments
10.2.5 MnM View
10.3 Boston Scientific Corporation
10.3.1 Business Overview
10.3.2 Boston Scientific Corporation: Company Snapshot
10.3.3 Product Offerings
10.3.4 Recent Developments
10.3.5 MnM View
10.4 ST. Jude Medical, Inc.
10.4.1 Business Overview
10.4.2 ST Jude Medical, Inc.: Company Snapshot
10.4.3 Product Offerings:
10.4.4 Recent Developments
10.4.5 MnM View
10.5 Cyberonics, Inc.
10.5.1 Business Overview
10.5.2 Cyberonics, Inc.: Company Snapshot
10.5.3 Product Portfolio
10.5.4 Recent Developments
10.6 Nevro Corporation
10.6.1 Business Overview
10.6.2 Nevro Corporation: Company Snapshot
10.6.3 Product Offerings
10.6.4 Recent Developments
10.7 Neurosigma, Inc.
10.7.1 Business Overview
10.7.2 Neurosigma, Inc.: Company Snapshot
10.7.3 Product Offerings
10.7.4 Recent Developments
10.8 Neuropace, Inc.
10.8.1 Business Overview
10.8.2 Neuropace, Inc.: Company Snapshot
10.8.3 Product Offerings
10.8.4 Recent Developments
10.9 Biocontrol Medical
10.9.1 Business Overview
10.9.2 Biocontrol Medical: Company Snapshot
10.9.3 Product Offerings
10.9.4 Recent Developments
10.10 Synapse Biomedical, Inc.
10.10.1 Business Overview
10.10.2 Synapse Biomedical, Inc.: Company Snapshot
10.10.3 Product Offerings
10.10.4 Recent Developments
10.11 Neuronetics, Inc.
10.12 Business Overview
10.12.1 Neuronetics, Inc.: Company Snapshot
10.12.2 Product and Service Offerings
10.12.3 Recent Developments

11 Appendix
11.1 Discussion Guide
11.2 Company Developments (2012-2015)
11.2.1 Medtronic, Inc.
11.2.2 Boston Scientific Corporation
11.2.3 ST Jude Medical, Inc.
11.2.4 Neurosigma, Inc.
11.3 Introducing RT: Real-Time Market Intelligence
11.4 Available Customizations
11.5 Related Reports

List of Tables

Table 1 Increasing Incidence of Neurological Disorders is Propelling the Growth of the Global Neuromodulation Market
Table 2 Unfavourable Reimbursement Structure is Restraining the Growth of the Global Neuromodulation Market
Table 3 Expansion in Emerging Markets has a Huge Potential for Growth in the Global Neuromodulation Market
Table 4 Global Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 5 Internal Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 6 Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 7 Internal Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 8 Spinal Cord Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 9 Spinal Cord Stimulation Market Size, 2013-2020 (Units)
Table 10 Deep Brain Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 11 Deep Brain Stimulation Market Size, 2013-2020 (Units)
Table 12 Vagus Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 13 Vagus Nerve Stimulation Market Size, 2013-2020 (Units)
Table 14 Sacral Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 15 Sacral Nerve Stimulation Market Size, 2013-2020 (Units)
Table 16 Gastric Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 17 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 18 External Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 19 External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 20 External Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 21 Transcutaneous Electrical Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 22 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 23 Transcranial Magnetic Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 24 Transcranial Magnetic Stimulation Market Size, 2013-2020 (Units)
Table 25 Respiratory Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 26 Respiratory Electrical Stimulation Market Size, 2013-2020 (Units)
Table 27 Global Spinal Cord Stimulation Market, By Application, 2013–2020 ($Million)
Table 28 Global Deep Brain Stimulation Market, By Application, 2013–2020 ($Million)
Table 29 Global Sacral Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 30 Global Vagus Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 31 Global Gastric Electrical Stimulation Market, By Application, 2013–2020 ($Million)
Table 32 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 33 Global Transcranial Magnetic Stimulation Market, By Application, 2013–2020 ($Million)
Table 34 Neuromodulation Market Size, By Region, 2013-2020($Million)
Table 35 North America: Neuromodulation Market Size, By Country, 2013–2020 ($Million)
Table 36 North America: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 37 North America: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 38 North America: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 39 U.S.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 40 U.S.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 41 U.S.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 42 Canada: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 43 Canada: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 44 Canada: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 45 Europe: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 46 Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 47 Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 48 Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 49 Germany: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 50 Germany: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 51 Germany: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 52 U.K.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 53 U.K.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 54 U.K.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 55 France: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 56 France: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 57 France: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 58 Rest of Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 59 Rest of Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 60 Rest of Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 61 Asia-Pacific: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 62 Asia-Pacific: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 63 Asia-Pacific: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 64 Asia-Pacific: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 65 Japan: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 66 Japan: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 67 Japan: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 68 China: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 69 China: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 70 China: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 71 India: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 72 India: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 73 India: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 74 ROAPAC: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 75 ROAPAC: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 76 ROAPAC: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 77 Rest of the World: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 78 Rest of the World: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 79 Rest of the World: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 80 Recent Developments, 2012–2014
Table 81 Recent Developments, 2012–2014
Table 82 Recent Developments, 2012–2014
Table 83 Recent Developments, 2012–2014
Table 84 Recent Developments, 2012–2014

List of Figures

Figure 1 Market Segmentation
Figure 2 Market Research Methodology Steps
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Internal Neuromodulation Segment to Witness the Highest CAGR of11.4% From 2015 to 2020
Figure 8 Deep Brain Stimulation to Grow at the Highest CAGR of 14.2% During the Forecast Period
Figure 9 Transcutaneous Electrical Nerve Stimulation is Expected to Command the Largest Share in 2015
Figure 10 Parkinson’s Disease is Expected to Command the Largest Share in 2015
Figure 11 Asia-Pacific Slated to Witness the Highest Growth in the Neuromodulation Market During the Forecast Period
Figure 12 Attractive Opportunities in the Neuromodulation Market
Figure 13 Internal Modulation Technology to Witness the Highest Growth During the Forecast Period
Figure 14 North America to Dominate the Neuromodulation Market
Figure 15 Deep Brain Stimulation Segment to Witness Highest Growth Rate During the Forecast Period
Figure 16 Asia-Pacific to Witness Highest Growth Rate From 2015 to 2020
Figure 17 Global Neuromodulation Market, By Type
Figure 18 Internal Neuromodulation Segment to Grow at the Highest CAGR of11.2% During the Forecast Period
Figure 19 Asia-Pacific to Grow at the Highest CAGR of 14.9% During the Forecast Period
Figure 20 Asia-Pacific to Grow at the Highest CAGR of 13.4% During the Forecast Period
Figure 21 Transcranial Magnetic Stimulation to Grow at the Highest CAGR During the Forecast Period
Figure 22 Global  Internal Neuromodulation  Market, By Application
Figure 23 Global  External Neuromodulation  Market, By Application
Figure 24 North America is Expected to Command the Largest Share of the Global Market in 2015
Figure 25 U.S. to Witness the Highest Growth in the Global Market in North America (2015)
Figure 26 Germany to Witness the Highest Growth in the Global Neuromodulation Market in Europe (2015)
Figure 27 Asia-Pacific, the Fastest-Growing Segment in the Global Market
Figure 28 RoW Expected to Grow at A CAGR of 13.3% During 2015 to 2020
Figure 29 Market Share Analysis of Neuromodulation, By Key Player, 2014
Figure 30 Neuromodulation Strategies Adopted By Key Players Over the Last Four Years (2012-2015)
Figure 31 Battle for Market Share of Neuromodulation: Market Develpoment was the Key Strategy
Figure 32 Neuromodulation Geographical Revenue Mix of Top Players

  • Zinc Bromide Industry Analysis, Trends and Forecast to 2020
    Global and Chinese Zinc Bromide (CAS7699-45-8) Industry, 2015 Market Research Report is a comprehensive research and 2015 market analysis by Prof Research, incorporating all the major phases and current market trends of in the Global and Chinese Zinc Bromide (CAS7699-45-8) Industry/market. The report commence with a brief introduction to the Zinc Bromide (CAS7699-45-8) along with [...]
  • Where is Healthcare Cloud Computing Market Going in Next 5 Years?
    Constant upsurge of IT n the field of healthcare has opened-up new business opportunities for cloud computing in the healthcare market. The basic requirement of cloud computing in healthcare industry is data-storage and data-integration that allows smooth data-access whenever required. Also, the need to collaborate a technologically advanced coordination between the patient and physician is [...]
  • Terminal Antennas Industry 2020 Forecasts for Global and Chinese Regions by Classification, Application & Manufacturing Technology
    Introduction: 2015 Terminal Antennas Industry Report – Global and Chinese Market 2015 Terminal Antennas Industry Report – Global and Chinese Market Scenario provide a detailed business insight on the trends of global and Chinese market. The report initially focuses on the existing technologies being used in the production of terminal antenas, the evolution of the [...]
  • Aluminum Heat Exchanger Consumption by Application and Type
    Global and Chinese Aluminum Heat Exchanger Industry, 2009-2019 Market Research Report is an in-depth market analysis of the current business situation and happenings of the Aluminum Heat Exchanger Industry. The report commence with a brief introduction to the industry, providing a description of the terminology used in the industry. The report further shares crucial stats [...]
  • Global and Chinese Calcium Heparin Market 2015 Analysis
    Synopsis – 2015 Calcium heparin Industry Report – Global and Chinese Market Scenario offers a thorough analysis of the entire Calcium Heparin industry. This report reviews each and every aspect of the Calcium Heparin industry and helps in effective decision making procedure.  A systematic breakup is provided to track down all possible barriers that can [...]
    • The Oil Drilling Rig Industry
    • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and se…

    • HER2-Negative Breast Cancer’s Therapeutic Market
    • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can …

    • The Market of Plate Heat Exchanger
    • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitat…

    • The Industry of Binding Machines
    • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the bind…

    • The Boom In Women Infertility Market
    • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Therapeutic Monoclonal Antibodies Markets
    Published: 01-Jun-2009        Price: US 1999 Onwards        Pages: 112
    Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through recombinant DNA technology that has the ability to combine specifically with a target protein that plays a role in a disease process. With this unique ability to specifically target diseased cells while leaving healthy cells unaffected, monoclonal......
  • Biochips - Products, Applications, Technologies And End-Use Markets Growth Analysis, 2009-2015
    Published: 28-Feb-2011        Price: US 6510 Onwards        Pages: 599
    Global Market Watch: Global biochips market is forecasted to reach US$9.1 billion by 2015 with a CAGR of 20.9% during 2009-2015; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 22.6% globally. Microarrays segment accounts for nearly 60% of the industry value while instruments, reagents and consumables together......
  • Circulating Tumor Cells (CTCs) Market Trends 2011
    Published: 01-Jul-2011        Price: US 1718 Onwards        Pages: 89
    This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastasis and mechanisms thereof. This report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for......
  • World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
    Published: 01-Feb-2012        Price: US 3800 Onwards        Pages: 220
    This research report on Anti-Infectives focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others) Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors, ......
  • Future US Flow Cytometry Market Outlook
    Published: 16-Feb-2012        Price: US 5900 Onwards        Pages: 174
    This report presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for major flow cytometry tests performed in US hospitals and commercial laboratories. Annual placements and installed base of major flow cytometers. Review of current ......
  • Future UK Flow Cytometry Markets Outlook
    Published: 16-Feb-2012        Price: US 3600 Onwards        Pages: 146
    This report presents a comprehensive analysis of the UK flow cytometry market, including: Major issues pertaining to the UK flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for major flow cytometry tests performed in UK hospitals and commercial laboratories. Annual placements and installed base of major flow cytometers. Review of current ......
  • Future Spanish Flow Cytometry Markets Outlook
    Published: 16-Feb-2012        Price: US 3600 Onwards        Pages: 140
    This report presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for major flow cytometry tests performed in Spanish hospitals and commercial laboratories. Annual placements and installed base of major flow cytometers. Rev......
  • Future Japanese Flow Cytometry Markets Outlook
    Published: 16-Feb-2012        Price: US 4500 Onwards        Pages: 142
    This report presents a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for major flow cytometry tests performed in Japanese hospitals and commercial laboratories. Annual placements and installed base of majo......
  • Future Italian Flow Cytometry Market Outlook
    Published: 16-Feb-2012        Price: US 3600 Onwards        Pages: 142
    This report presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for major flow cytometry tests performed in Italian hospitals and commercial laboratories. Annual placements and installed base of major flow cytometers. Rev......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs